Accredited Investor email list Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for accredited investor in the search bar above.
By completing this form, you are giving consent to receive communication from Silo Wellness using the contact information you provide. And remember you can unsubscribe at any time.
Silo Wellness’ Management Team & Board of Directors
Douglas Gordon CEO (Jamaica)
Douglas Gordon is the founder of CanEx Jamaica, the premier cannabis business conference and expo in the Caribbean. He has over 30 years of experience spanning finance, media, sales and marketing. Gordon has forged a vast global network with particular attention to developing business opportunities in the Caribbean and LATAM. Gordon has developed government and distribution relations i
Halo Collective Taps Have a Heart s CEO Ryan Kunkel
Halo Collective Inc. (NEO:HALO)(OTCQX:AGEEF) has welcomed Have a Heart s CEO and founder Ryan Kunkel to serve as its vice-chairman and an independent director.
Kunkel is a seasoned cannabis expert and entrepreneur with experience in operations, fundraising, and application development. As our operations continue to expand and we open our first dispensaries in Los Angeles and acquire Kush Bar dispensaries from High Tide in Alberta, Canada, it s imperative for Halo to look at the big picture and bring Ryan to our senior team, Louisa Mojela, the company s executive chairman, said Friday.
Psychedelics Could be Your Next Multi-Billion-Dollar Opportunity
It may only be a matter of time before mind-altering drugs make their way into Big Pharma treatments for mental health issues, such as depression, anxiety, obsessive compulsive disorder, trauma, and addiction. If that happens, the industry could be worth well over $100 billion, as noted by analyst at Eight Capital, benefiting companies such as
Silo Wellness (CSE:SINO),
Compass Pathways Inc. (NASDAQ:CMPS),
HAVN Life Sciences Inc. (CSE:HAVN), and
Tryp Therapeutics Inc. (CSE:TRYP).
Helping even more, a bill to decriminalize psychedelics in California is moving forward. In fact, according to Benzinga, “Introduced in February by Sen. Scott Wiener, SB 519 would remove penalties for the possession, personal use and social sharing of certain natural and synthetic psychoactive drugs including psilocybin, psilocyn, DMT, ibogaine, mescaline, LSD, ketamine and MDMA.”